Key metrics and charts across all fundamental categories.
Stock price and market valuation
THC trades at $180.88, a 34.5% increase year-over-year. Market capitalization stands at $15.70B, up 23.9% from the prior year. Track THC price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$21.45B in TTM revenue grew 4.6% YoY, reaching $5.37B last quarter. TTM EBITDA of $4.75B on operating income of $1.30B shows growth is flowing through. Net income of $2.65B TTM confirms the company is converting revenue into profit. Revenue is growing modestly — monitor for acceleration or deceleration.
Assets, cash, debt, and leverage
With $31.20B in assets and $13.13B in long-term debt, the D/E of 2.7 indicates elevated leverage — the company has significant financial risk and may struggle in a downturn.
Price multiples and return ratios
At 5.9x P/E, the stock trades below market averages — potentially undervalued. P/S of 0.7x and P/B of 3.3x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 24.1% is up 6.1% YoY — cost efficiency is improving. Net margin at 16.9%. ROE of 55.1% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $1.46B on $1.64B in operating cash flow. The FCF / Net Income ratio of 0.6x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $2.97B provide financial flexibility. Shares outstanding declined 7.9% YoY — buybacks are returning capital to shareholders.
